Marion Zerlin

1.3k total citations
19 papers, 1.1k citations indexed

About

Marion Zerlin is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Marion Zerlin has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Pharmacology and 3 papers in Organic Chemistry. Recurrent topics in Marion Zerlin's work include Microbial Natural Products and Biosynthesis (6 papers), Biochemical and Structural Characterization (3 papers) and Peptidase Inhibition and Analysis (3 papers). Marion Zerlin is often cited by papers focused on Microbial Natural Products and Biosynthesis (6 papers), Biochemical and Structural Characterization (3 papers) and Peptidase Inhibition and Analysis (3 papers). Marion Zerlin collaborates with scholars based in Germany, United States and Belgium. Marion Zerlin's co-authors include Edson X. Albuquerque, Marek Samochocki, Ruth Jostock, Alfred Maelicke, Ralf Thiericke, Jürgen Ludwig, Susanne Grabley, Claudia Christner, Gerald Dräger and Andreas Kirschning and has published in prestigious journals such as Analytical Biochemistry, Biological Psychiatry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Marion Zerlin

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marion Zerlin Germany 15 561 549 371 183 84 19 1.1k
Jiro Itoh Japan 19 366 0.7× 695 1.3× 251 0.7× 539 2.9× 39 0.5× 36 1.5k
Timothy J. Hagen United States 23 359 0.6× 908 1.7× 655 1.8× 290 1.6× 37 0.4× 68 1.7k
Esther García‐Palomero Spain 17 891 1.6× 653 1.2× 306 0.8× 441 2.4× 26 0.3× 23 1.7k
Mark W. Dudley United States 21 133 0.2× 524 1.0× 362 1.0× 365 2.0× 21 0.3× 38 1.3k
Naoki Yamazaki Japan 26 184 0.3× 704 1.3× 1.0k 2.8× 257 1.4× 88 1.0× 89 2.0k
Walter Weyler United States 23 107 0.2× 979 1.8× 296 0.8× 361 2.0× 31 0.4× 42 1.9k
Thomas Balle Denmark 26 294 0.5× 1.3k 2.4× 416 1.1× 417 2.3× 57 0.7× 91 2.0k
Pieter G. Tepper Netherlands 26 118 0.2× 948 1.7× 379 1.0× 682 3.7× 63 0.8× 62 1.8k
Laurence R. Meyerson United States 23 212 0.4× 650 1.2× 172 0.5× 775 4.2× 59 0.7× 56 1.5k
Yukiko Makino Japan 18 138 0.2× 255 0.5× 124 0.3× 401 2.2× 65 0.8× 40 1.0k

Countries citing papers authored by Marion Zerlin

Since Specialization
Citations

This map shows the geographic impact of Marion Zerlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Zerlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Zerlin more than expected).

Fields of papers citing papers by Marion Zerlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Zerlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Zerlin. The network helps show where Marion Zerlin may publish in the future.

Co-authorship network of co-authors of Marion Zerlin

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Zerlin. A scholar is included among the top collaborators of Marion Zerlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Zerlin. Marion Zerlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Samochocki, Marek, Ruth Jostock, Jürgen Ludwig, et al.. (2003). Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors. Journal of Pharmacology and Experimental Therapeutics. 305(3). 1024–1036. 289 indexed citations
2.
Maelicke, Alfred, Marek Samochocki, Ruth Jostock, et al.. (2001). Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer’s disease. Biological Psychiatry. 49(3). 279–288. 258 indexed citations
3.
Samochocki, Marek, Marion Zerlin, Ruth Jostock, et al.. (2000). Galantamine is an allosterically potentiating ligand of the human α4/β2 nAChR. Acta Neurologica Scandinavica. 102. 68–73. 132 indexed citations
4.
5.
Sattler, Isabel, Marion Zerlin, Claudia Hinze, et al.. (1999). Biomolecular-chemical Screening. A Novel Screening Approach for the Diseovery of Biologically Active Seeondary Metabolites. III. New DNA-binding Metabolites.. The Journal of Antibiotics. 52(12). 1124–1134. 27 indexed citations
6.
7.
Christner, Claudia, Gerhard Küllertz, Gunter Fischer, et al.. (1998). Albocycline- and Carbomycin-type Macrolides, Inhibitors of Human Prolyl Endopeptidases.. The Journal of Antibiotics. 51(3). 368–371. 20 indexed citations
8.
Dräger, Gerald, et al.. (1998). First Glycosylation of Decarestrictine B and D: A Route to Hybrid Antibiotics. Chemistry - A European Journal. 4(7). 1324–1333. 15 indexed citations
9.
Piehler, Jacob, Andreas Brecht, Günter Gauglitz, et al.. (1997). Label-Free Monitoring of DNA–Ligand Interactions. Analytical Biochemistry. 249(1). 94–102. 48 indexed citations
10.
RITZAU, M., Wolfgang Ihn, Brigitte Schlegel, et al.. (1997). Lipohexin, a New Inhibitor of Prolyl Endopeptidase from Moeszia lindtneri (HKI-0054) and Paecilomyces sp. (HKI-0055; HKI-0096). I. Screening, Isolation and Structure Elucidation.. The Journal of Antibiotics. 50(5). 379–383. 21 indexed citations
11.
12.
13.
Piehler, Jacob, et al.. (1997). Specific binding of low molecular weight ligands with direct optical detection. Biosensors and Bioelectronics. 12(6). 531–538. 23 indexed citations
14.
Grabley, Susanne, et al.. (1996). New Albrassitriols from Aspergillus sp. (FH-A 6357).. The Journal of Antibiotics. 49(6). 593–595. 16 indexed citations
15.
Dräger, Gerald, Andreas Kirschning, Ralf Thiericke, & Marion Zerlin. (1996). Decanolides, 10-membered lactones of natural origin. Natural Product Reports. 13(5). 365–375. 105 indexed citations
16.
Zeeck, Axel, et al.. (1996). Secondary Metabolites by Chemical Screening. 30. Helmidiol, a New Macrodiolide from Alternaria alternata. Journal of Natural Products. 59(5). 539–540. 33 indexed citations
17.
Grabley, Susanne, et al.. (1996). ChemInform Abstract: New Albrassitriols from Aspergillus sp. (FH‐A 6357).. ChemInform. 27(47). 1 indexed citations
18.
Thiericke, Ralf & Marion Zerlin. (1996). Manipulation of Microbial Metabolite Pattern. 1. Initiation of Obscurolide Biosynthesis in a Streptozoline-producing Streptomycetes Strain. Natural product letters. 8(3). 163–167. 8 indexed citations
19.
Zerlin, Marion & Ralf Thiericke. (1994). Common Principles in Macrolactone (Marginolactone) Biosynthesis. Studies on the Desertomycin Family. The Journal of Organic Chemistry. 59(23). 6986–6993. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiro Itoh Breakdown of academic impact, for papers by Timothy J. Hagen Breakdown of academic impact, for papers by Esther García‐Palomero Breakdown of academic impact, for papers by Mark W. Dudley Breakdown of academic impact, for papers by Naoki Yamazaki Breakdown of academic impact, for papers by Walter Weyler Breakdown of academic impact, for papers by Thomas Balle Breakdown of academic impact, for papers by Pieter G. Tepper Breakdown of academic impact, for papers by Laurence R. Meyerson Breakdown of academic impact, for papers by Yukiko Makino
Rankless by CCL
2026